Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients. Journal of Renal and Hepatic Disorders, v. 4, n. 1, p. 22–30, 18 May2020.